Pharmababble

Biomedical investment and business development chatter

Things categorized as 'Company Shakeups'

Neurogen Sells The Farm(house)… Literally

Posted on November 14th .

Neurogen announced it has entered into agreements to monetize some of its non-core assets including certain research facilities and its chemical library. Included within this group ...

Another CB-1 Antagonist Bites the Dust: Pfizer Cancels CP-945,598

Posted on November 5th .

Not a shocking decision given the issues with other doomed CB1 antagonist programs but why didn't this happen a year ago? Pfizer Discontinues Development Program ...

(preview-image)

Archer Pharmaceuticals Launches to Target Alzheimer’s Disease

Posted on October 22nd .

[caption id="" align="alignleft" width="202" caption="Image via Wikipedia"][/caption] This has to be the worst time in a decade to found a company. Nobody told Read More →

(preview-image)

Pfizer Waging Battle Over Ranbaxy??

Posted on June 13th .

Image via Wikipedia I was on a plane all day, headed to the BIO-LES seminar and didn't get a chance to read ...

(preview-image)

Jazz Pharmaceuticals in Trouble… Still

Posted on June 11th .

Image via Wikipedia I always felt a company marketing a date rape drug (Read More →

(preview-image)

TEVA Gets Taste of Own Medicine

Posted on June 10th .

The Israeli generic drug maker, known for its aggressive tactics is getting a taste of its own medicine if ...

(preview-image)

Big Pharma Tries to Shake Things Up

Posted on June 10th .

Image by Getty Images via Daylife GSK to shake-up research strategies (Financial Times) Read More →

(preview-image)

Ipsen Buys Into North America

Posted on June 5th .

Image via Wikipedia So how much does it cost for an EU pharmaceutical company to break into the North American market? Read More →

So You Wanna Be CEO?

Posted on June 3rd .

New research reveals the most popular routes into the executive suite Hat tip to Dealbreaker, via The Economist.

Enzon Shareholders Revolt…. kind of.

Posted on May 21st .

A while back, I wrote a post detailing my confused wonder at a proposed spin-off from Enzon of a biotech with all of the ...

(preview-image)

Icahn Steals The Future of Enzon Pharmaceuticals

Posted on May 7th .

Enzon Pharmaceuticals, on the reported urging of uber-investor Carl Icahn, will spin off a NewCo along with the majority of the company's core ...

Bristol-Myers Squibb To Be Acquired By… [Insert Name Here]??

Posted on May 6th .

In a previous post, I speculated on reasons for shedding of non-core pharmaceutical assets by BMS. Don't read it. I was grasping ...

BMS Sheds ConvaTec for $4.1 billion

Posted on May 4th .

A few hours after I had written this post about the Pfizer/Esperion spin-off signaling a changing of the times in big pharma, I see ...

Does the Esperion Spin-Off Signal the Start of New R&D Era?

Posted on May 2nd .

What a difference time makes. Pfizer acquired Esperion roughly 4 years ago at a 53% premium and a price tag of $1.3 billion dollars. Yesterday, ...

Kindler Talks to Mike Huckman About Pfizer Woes

Posted on April 25th .

Good article, great interview. Kindler answers tough questions candidly with quality answers. Check out the video and blog post here.